{"content":"<li class=\"n-box-item date-title\" data-end=\"1381809599\" data-start=\"1381723200\" data-txt=\"Friday, December 20, 2019\">Monday, October 14, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1327532\" data-ts=\"1381790565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLIC\" target=\"_blank\">KLIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1327532-kulicke-and-soffe-closes-up-sharply-in-response-to-barrons-column\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kulicke &amp; Soffe closes up sharply in response to Barron&#39;s column</a></h4><ul><li><a href=\"http://online.barrons.com/article/SB50001424053111903891504579125512737104166.html?mod=BOLFeed#articleTabs_article%3D1\" target=\"_blank\"><em>Barron</em><em>'s </em>declares</a> Kulicke &amp; Soffe (<a href='https://seekingalpha.com/symbol/KLIC' title='Kulicke and Soffa Industries, Inc.'>KLIC</a> <font color='green'>+9.5%</font>) \"a company that looks ripe for an activist investor.\" given its giant cash balance (accounts for $508.5M of a $997M market cap), lack of a dividend or buyback plan, and a dominant position in the <a href=\"http://en.wikipedia.org/wiki/Wire_bonding\" target=\"_blank\">wire bonding</a> segment of the chip equipment industry.</li><li>K&amp;S says it needs to keep the cash in case an M&amp;A opportunity arises. However, the company has spent little on acquisitions as of late, and its <a href=\"http://www.bloomberg.com/apps/news?pid=newsarchive&amp;sid=a9wMKCBdUPLI\" target=\"_blank\">past deals</a> haven't fared particularly well.</li><li>Two risks: K&amp;S is vulnerable to cyclical swings - revenue is expected to be down 31.3% Y/Y in FY13 (ended Sep. '13) before rising 22.7% in FY14 - and there are concerns wire bonding (though still used to make 85% of chips) will be gradually displaced by newer technologies.</li></ul><div class=\"tiny-share-widget\" data-id=\"1327532\" data-linked=\"Kulicke &amp; Soffe closes up sharply in response to Barron&#39;s column\" data-tweet=\"$KLIC - Kulicke &amp; Soffe closes up sharply in response to Barron&#39;s column https://seekingalpha.com/news/1327532-kulicke-and-soffe-closes-up-sharply-in-response-to-barrons-column?source=tweet\" data-url=\"https://seekingalpha.com/news/1327532-kulicke-and-soffe-closes-up-sharply-in-response-to-barrons-column\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1327452\" data-ts=\"1381787193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1327452-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours Gainers / Losers</a></h4><ul>     <li><b>Top Gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/FU' title='FAB Universal Corp.'>FU</a> <font color='green'>+2.2%</font>. <a href='https://seekingalpha.com/symbol/COCO' title='Corinthian Colleges, Inc.'>COCO</a> <font color='green'>+2.0%</font>. SHLD <font color='green'>+1.5%</font>. MCP <font color='green'>+1.4%</font>.</li><li><b>Top Losers, </b><b><b>as of 5:15 p.m</b>:</b> <a href='https://seekingalpha.com/symbol/TDC' title='Teradata Corporation'>TDC</a> <font color='red'>-10.6%</font>. <a href='https://seekingalpha.com/symbol/THOR-OLD' title='Thoratec Corporation'>THOR-OLD</a> <font color='red'>-4.3%</font>. <a href='https://seekingalpha.com/symbol/XYL' title='Xylem, Inc.'>XYL</a> <font color='red'>-4.1%</font>. RSO <font color='red'>-2.9%</font>. NOR <font color='red'>-2.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1327452\" data-linked=\"After-hours Gainers / Losers\" data-tweet=\"$VXX $FU $COCO - After-hours Gainers / Losers https://seekingalpha.com/news/1327452-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1327452-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1327432\" data-ts=\"1381785586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DASTY\" target=\"_blank\">DASTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1327432-dassault-falls-after-missing-q3-revenue-forecast-paring-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dassault falls after missing Q3 revenue forecast, paring guidance</a></h4><ul>     <li>Dassault (<a href=\"https://seekingalpha.com/symbol/DASTY\" title=\"Dassault Systemes SA ADR\">OTCPK:DASTY</a>) <font color=\"red\">fell 10.5%</font> in Paris after reporting preliminary Q3 revenue of \u20ac496 ($673M, +4% Y/Y exc. forex), below guidance of \u20ac520M. EPS fell 1% \u20ac0.88 ($1.19). \u20ac12M of the shortfall is blamed on deal slippage (particularly in Asia), \u20ac4M on weaker-than-expected services revenue, and \u20ac8M on a shift among SMB clients towards rental/subscription licensing relative to up-front payments.</li>     <li>While revenue rose 7% Y/Y in Europe, it only rose 2% in Asia and 1% in the Americas. Importantly, new license revenue (drives future revenue streams) fell 10% Y/Y. Recurring software revenue (77% of total) rose 8%.</li>     <li>In addition, the 3D product design/testing software firm <a href=\"http://in.reuters.com/article/2013/10/14/dassaultsystemes-idINL6N0I405Y20131014\" target=\"_blank\">guided</a> on a CC (<a href=\"https://seekingalpha.com/article/1743952-dassault-systemes-sa-management-discusses-preliminary-q3-2013-results-earnings-call-transcript?source=yahoo\" target=\"_blank\">transcript</a>) for full-year revenue growth of 4%-5%, below a prior 7%-8%. Q4 revenue is expected to total at least \u20ac565M ($766M, +5% Y/Y exc. forex), and EPS guidance is set at \u20ac0.97.</li>     <li>Full Q3 results arrive on Oct. 24.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1327432\" data-linked=\"Dassault falls after missing Q3 revenue forecast, paring guidance\" data-tweet=\"$DASTY - Dassault falls after missing Q3 revenue forecast, paring guidance https://seekingalpha.com/news/1327432-dassault-falls-after-missing-q3-revenue-forecast-paring-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1327432-dassault-falls-after-missing-q3-revenue-forecast-paring-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1327392\" data-ts=\"1381784671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PKG\" target=\"_blank\">PKG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1327392-packaging-corp-beats-by-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Packaging Corp beats by $0.02, beats on revenue</a></h4><ul>     <li>Packaging Corp (NYSE:<a href=\"https://seekingalpha.com/symbol/PKG\" title=\"Packaging Corporation Of America\">PKG</a>): Q3 EPS of $0.91 <font color=\"green\">beats by $0.02</font>.</li>\n<li>Revenue of $845.4M <font color=\"green\">beats by $14.7M</font>. Shares<font color=\"green\"> +2.51%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1327392\" data-linked=\"Packaging Corp beats by $0.02, beats on revenue\" data-tweet=\"$PKG - Packaging Corp beats by $0.02, beats on revenue https://seekingalpha.com/news/1327392-packaging-corp-beats-by-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1327392-packaging-corp-beats-by-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1327352\" data-ts=\"1381783719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDC\" target=\"_blank\">TDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1327352-teradata-issues-q3-2013-warning-shares-minus-11_1-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teradata issues Q3/2013 warning, shares -11.1% AH</a></h4><ul>\n<li>Teradata (NYSE:<a href=\"https://seekingalpha.com/symbol/TDC\" title=\"Teradata Corporation\">TDC</a>) expects to Q3 revenue of $665M and EPS of $0.69-$0.70, below a consensus of $698.9M and $0.81. In addition, the company is now guiding for full-year revenue to be flat Y/Y and EPS to be in a range of $2.70-$2.80; the consensus is for 4.5% growth and EPS of $3.05. (PR)</li>\n<li>Though Teradata believes its Americas and European revenue rose 7% and 13% Y/Y in Q3, respectively, Asia-Pac/Japan and Middle East/Africa are believed to have seen declines of 21% and 19%. Americas revenue rose 2% Y/Y in Q2, while its international revenue fell 1%.</li>\n<li>$300M has been added to Teradata's buyback plan, raising the company's total repurchase authorization to $509M (good for repurchasing 6.7% of shares at current levels).</li>\n<li>Teradata <a href=\"https://seekingalpha.com/currents/post/1185882\" target=\"_blank\">shot higher</a> in August after reporting better-than-feared Q2 results and reiterating EPS guidance. But shares were pressured earlier this year by <a href=\"https://seekingalpha.com/currents/post/994221\" target=\"_blank\">earning woes</a> and concerns about share loss.</li>\n<li>With Teradata now guiding for no revenue growth in a year when several peers are expected to post solid growth for their data warehousing and analytics product lines, those concerns might pop up again. On the other hand, defenders are likely to point to the regional disparities in Teradata's numbers as proof the company's problems are related to sales execution.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1327352\" data-linked=\"Teradata issues Q3/2013 warning, shares -11.1% AH\" data-tweet=\"$TDC - Teradata issues Q3/2013 warning, shares -11.1% AH https://seekingalpha.com/news/1327352-teradata-issues-q3-2013-warning-shares-minus-11_1-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1327352-teradata-issues-q3-2013-warning-shares-minus-11_1-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1327202\" data-ts=\"1381781124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XAN\" target=\"_blank\">XAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1327202-resource-capital-launches-100m-convertible-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Resource Capital launches $100M convertible offering</a></h4><ul>\n<li>The notes will be due in 2018 with underwriters expected to be granted an option to purchase up to an additional $15M of the paper.</li>\n<li>RSO <font color=\"red\">-4.5%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1327202\" data-linked=\"Resource Capital launches $100M convertible offering\" data-tweet=\"$XAN - Resource Capital launches $100M convertible offering https://seekingalpha.com/news/1327202-resource-capital-launches-100m-convertible-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1327202-resource-capital-launches-100m-convertible-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1327132\" data-ts=\"1381779606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACOR\" target=\"_blank\">ACOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1327132-acorda-therapeutics-falls-after-announcing-results-of-dalfampridine-post-stroke-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acorda Therapeutics falls after announcing results of dalfampridine post-stroke study</a></h4><ul>\n<li>Acorda Therapeutics (<a href=\"https://seekingalpha.com/symbol/ACOR\" title=\"Acorda Therapeutics, Inc.\">ACOR</a> <font color=\"red\">-8.4%</font>) falls despite reporting what the company calls \"positive\" results for a dalfampridine-ER proof-of-concept study in patients with post-stroke deficits.</li>\n<li>The treatment was \"was well-tolerated and improved walking, as measured by       the Timed 25-Foot Walk test.\" (PR)</li>\n<li>RBC's Michael Yee says that while the post-stroke data \"is interesting,\" it is \"<a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/10/14/mannkind-gains-acorda-therapeutics-loses-as-trial-results-released/\" target=\"_blank\">not as compelling</a> versus the MS indication.\"</li>\n<li>Speaking of the MS indication, Yee says \"scripts look a bit mediocre tracking a tad shy of Q3 consensus, and overall new scripts are down too.\"</li>\n<li>Nevertheless, RBC says \"expectations are pretty low and ... the stock is pretty cheap at  $1.1B EV or ~3x sales plus all potential upside from label expansion or  pipeline.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1327132\" data-linked=\"Acorda Therapeutics falls after announcing results of dalfampridine post-stroke study\" data-tweet=\"$ACOR - Acorda Therapeutics falls after announcing results of dalfampridine post-stroke study https://seekingalpha.com/news/1327132-acorda-therapeutics-falls-after-announcing-results-of-dalfampridine-post-stroke-study?source=tweet\" data-url=\"https://seekingalpha.com/news/1327132-acorda-therapeutics-falls-after-announcing-results-of-dalfampridine-post-stroke-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1327032\" data-ts=\"1381777022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCPI\" target=\"_blank\">RCPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1327032-lively-debate-on-star-scientific\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lively debate on Star Scientific</a></h4><ul> <li>The situation at Star Scientific (STSI <font color=\"green\">+0.9%</font>) is <a href=\"https://seekingalpha.com/article/1744142-star-scientific-cash-strapped-and-under-the-influence-of-death-spiral-financing?source=feed_f\" target=\"_blank\">bleak</a>, according to SA contributor Paulo Santos.</li> <li>He thinks the company's desperate measure to raise capital through the issuance of new shares is just buying time with hopes for a revenue bonanza fading.</li> <li>The bull case on STSI hinges on the potential for Anatabloc to be a mass market product. The company expects a patent related to the treatment's active ingredient to be granted shortly.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1327032\" data-linked=\"Lively debate on Star Scientific\" data-tweet=\"$RCPI - Lively debate on Star Scientific https://seekingalpha.com/news/1327032-lively-debate-on-star-scientific?source=tweet\" data-url=\"https://seekingalpha.com/news/1327032-lively-debate-on-star-scientific\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326992\" data-ts=\"1381776694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326992-acadia-jumps-as-article-predicts-blockbuster-pimavanserin-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia jumps as article predicts blockbuster pimavanserin sales</a></h4><ul>\n<li>Acadia Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ACAD\" title=\"ACADIA Pharmaceuticals Inc.\">ACAD</a> <font color=\"green\">+9.3%</font>) is enjoying a strong session.</li>\n<li>Perhaps helping to tip sentiment is SA Contributor Brian Nichols, <a href=\"https://seekingalpha.com/article/1743612-pimavanserin-the-most-underestimated-blockbuster-in-biotechnology\" target=\"_blank\">who says</a> the company's antipsychotic drug pimavanserin has \"<em>the greatest sales potential since Lipitor</em>\" \u2014 good news, considering Lipitor is the best-selling drug in pharmaceutical history.</li>\n<li>Nichols goes on to predict peak global sales of $20.45B, and says his \"five key points ... suggest that sales could be even greater.\"</li>\n<li>As for a target price, Nichols says three times sales for companies with assumed blockbusters (cited are Alexion and Pharmacyclics) isn't unreasonable, and just to be on the safe side, the author discounts peak sales by \"a whopping 50%,\" then multiplies $10B times three to get a valuation of ~$30B.</li>\n<li>Ultimately, Nichols says \"a target price over $300 is not unrealistic.\" This represents upside of around <font color=\"green\">1,295%</font> from Friday's close.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1326992\" data-linked=\"Acadia jumps as article predicts blockbuster pimavanserin sales\" data-tweet=\"$ACAD - Acadia jumps as article predicts blockbuster pimavanserin sales https://seekingalpha.com/news/1326992-acadia-jumps-as-article-predicts-blockbuster-pimavanserin-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/1326992-acadia-jumps-as-article-predicts-blockbuster-pimavanserin-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326972\" data-ts=\"1381775825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326972-barclays-considers-alcatel-nokia-m-and-a-speculation-credible\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays considers Alcatel-Nokia M&amp;A speculation credible</a></h4><ul>\n<li>\n<a href=\"http://www.streetinsider.com/Upgrades/Barclays+Raises+Alcatel-Lucent+%28ALU%29+to+Overweight%2C+Cuts+Ericsson+%28ERIC%29+to+Underweight/8773287.html\" target=\"_blank\">Barclays</a>, which <a href=\"https://seekingalpha.com/currents/post/1326192\" target=\"_blank\">upgraded</a> Alcatel-Lucent (ALU <font color=\"green\">+4.3%</font>) to Overweight and cut Ericsson (<a href=\"https://seekingalpha.com/symbol/ERIC\" title=\"LM Ericsson Telephone Company\">ERIC</a> <font color=\"red\">-1.9%</font>) to Underweight this morning, thinks <a href=\"https://seekingalpha.com/currents/post/1255922\" target=\"_blank\">speculation</a> about a merger between Alcatel and Nokia (<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a> <font color=\"red\">-0.5%</font>) is credible, and sees the combined company providing tougher competition for Ericsson (currently the mobile infrastructure market's top vendor).</li>\n<li>There have been <a href=\"https://seekingalpha.com/currents/post/1299202\" target=\"_blank\">reports</a> Nokia, set to reap a $7.2B windfall from the Microsoft deal, is thinking of approaching Alcatel about a tie-up. However, no talks are believed to be underway, and the reports didn't explicitly state Nokia is eying a full-blown merger.</li>\n<li>Mergers between major networking/telecom equipment vendors have often yielded share losses rather than gains in the quarters following the deal's completion, thanks to both integration challenges and efforts by common customers to diversify their supplier lists. Alcatel's merger with Lucent acts as an example.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1326972\" data-linked=\"Barclays considers Alcatel-Nokia M&amp;A speculation credible\" data-tweet=\"$NOK $NOK $ERIC - Barclays considers Alcatel-Nokia M&amp;A speculation credible https://seekingalpha.com/news/1326972-barclays-considers-alcatel-nokia-m-and-a-speculation-credible?source=tweet\" data-url=\"https://seekingalpha.com/news/1326972-barclays-considers-alcatel-nokia-m-and-a-speculation-credible\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326942\" data-ts=\"1381773990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWR\" target=\"_blank\">SPWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326942-u-s-solar-names-rally-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. solar names rally again</a></h4><ul>\n<li>SunPower (<a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a> <font color=\"green\">+5.2%</font>), First Solar (<a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a> <font color=\"green\">+2.7%</font>), and SunEdison (SUNE <font color=\"green\">+3.4%</font>) are all adding to the <a href=\"https://seekingalpha.com/currents/post/1324462\" target=\"_blank\">Friday gains</a> they saw after SolarCity provided strong Q3 installation data and (more importantly) issued better-than-expected <a href=\"https://seekingalpha.com/currents/post/1324342\" target=\"_blank\">2014 guidance</a>. SolarCity is taking a breather following Friday's giant move higher.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1319612\" target=\"_blank\">Last week's signing</a> of a California solar bill that effectively allows solar power producers (residential or commercial) to sell back as much excess power to the grid as they generate (the bill could pave the way for similar legislation in other states) could also be providing a lift to industry sentiment.</li>\n<li>Short interests for the group remain high. SunPower had 27.7% of its float shorted as of Sep. 30, First Solar had 15.2%, and SunEdison 10%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1326942\" data-linked=\"U.S. solar names rally again\" data-tweet=\"$SPWR $SPWR $FSLR - U.S. solar names rally again https://seekingalpha.com/news/1326942-u-s-solar-names-rally-again?source=tweet\" data-url=\"https://seekingalpha.com/news/1326942-u-s-solar-names-rally-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326892\" data-ts=\"1381771785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326892-morgan-stanley-downgrades-mylan-says-long-term-growth-story-intact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley downgrades Mylan, says long-term growth story intact</a></h4><ul>\n<li>Mylan (<a href=\"https://seekingalpha.com/symbol/MYL\" title=\"Mylan Inc\">MYL</a> <font color=\"red\">-1.7%</font>) is suffering through a rough session, underperforming both the broad market and the NASDAQ Biotech Index.</li>\n<li>Earlier, Morgan Stanley <a href=\"http://www.streetinsider.com/Downgrades/Morgan+Stanley+Downgrades+Mylan+%28MYL%29+to+Equalweight/8773107.html\" target=\"_blank\">downgraded</a> the shares to Equalweight from Overweight and removed a $41 price target.</li>\n<li>Although analyst David Risinger <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/10/3988595/update-morgan-stanley-downgrades-mylan-on-binary-near-te\" target=\"_blank\">believes</a> the \"long-term growth outlook remains robust [thanks in part to] a compelling pipeline of  high-value, limited competition opportunities in the U.S.,\" he steps to the sidelines, saying the \"market now better appreciates the strength and durability of Mylan's global platform.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1326892\" data-linked=\"Morgan Stanley downgrades Mylan, says long-term growth story intact\" data-tweet=\"$MYL - Morgan Stanley downgrades Mylan, says long-term growth story intact https://seekingalpha.com/news/1326892-morgan-stanley-downgrades-mylan-says-long-term-growth-story-intact?source=tweet\" data-url=\"https://seekingalpha.com/news/1326892-morgan-stanley-downgrades-mylan-says-long-term-growth-story-intact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326812\" data-ts=\"1381769918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XPO\" target=\"_blank\">XPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326812-xpo-logistics-gets-another-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XPO Logistics gets another upgrade</a></h4><ul>\n<li>XPO Logistics (<a href=\"https://seekingalpha.com/symbol/XPO\" title=\"XPO Logistics, Inc\">XPO</a> <font color=\"green\">+1.8%</font>) gets its second <a href=\"http://www.streetinsider.com/Analyst+Comments/FBR+Capital+Upgrades+XPO+Logistics+%28XPO%29+to+Outperform/8772965.html\" target=\"_blank\">upgrade</a> in less than a week as FBR takes the shares to Outperform from Market Perform.</li>\n<li>Analyst John Mims thinks \"now is the time to start building positions [as] we are quickly approaching the point of critical mass at which  the XPO story evolves from one of pure growth, to one of sustained  profitability and industry-leading growth.\"</li>\n<li>\"Over the next several years, we expect XPO shares to move up in a  stair-step pattern, based on timing of alpha-generating catalysts such  as meaningful acquisitions and profitability milestones, and given that  the stock is relatively thin,\" Mims adds.</li>\n<li>Price target hiked to $30 from $18.</li>\n<li>Last week, Stifel <a href=\"http://www.streetinsider.com/Upgrades/Stifel+Nicolaus+Upgrades+XPO+Logistics+%28XPO%29+to+Buy/8766348.html\" target=\"_blank\">upgraded</a> the shares to Buy from Hold.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1326812\" data-linked=\"XPO Logistics gets another upgrade\" data-tweet=\"$XPO - XPO Logistics gets another upgrade https://seekingalpha.com/news/1326812-xpo-logistics-gets-another-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1326812-xpo-logistics-gets-another-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326802\" data-ts=\"1381769809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326802-bristow-group-raised-to-buy-at-global-hunter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow Group raised to Buy at Global Hunter</a></h4><ul>     <li>Bristow Group (<a href=\"https://seekingalpha.com/symbol/BRS\" title=\"Bristow Group Inc.\">BRS</a> <font color=\"green\">+3.6%</font>) is <a href=\"http://www.streetinsider.com/Upgrades/UPDATE%3A+Global+Hunter+Securities+Upgrades+Bristow+Group+%28BRS%29+to+Buy/8773561.html\" target=\"_blank\">upgraded to Buy</a> from Speculative Buy with a $98 price target, up from $77, at Global Hunter, which expects BRS to beat the quarter and raise annual guidance which in turn will result in upward revisions to the Street's FY 2015 and 2016 expectations.</li>     <li>The firm thinks an improved returns profile, recent share gains likely to accelerate given the stranglehold on the industry's order  and options book, and likely 20%-plus earnings growth vs. the 10%-15% guidance will change how investors value the stock,  moving away from NAV to earnings.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1326802\" data-linked=\"Bristow Group raised to Buy at Global Hunter\" data-tweet=\"$BRS - Bristow Group raised to Buy at Global Hunter https://seekingalpha.com/news/1326802-bristow-group-raised-to-buy-at-global-hunter?source=tweet\" data-url=\"https://seekingalpha.com/news/1326802-bristow-group-raised-to-buy-at-global-hunter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326792\" data-ts=\"1381769399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBC\" target=\"_blank\">AMBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326792-puerto-rico-munis-plummet-6_6-percent-in-october\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Puerto Rico munis plummet 6.6% in October</a></h4><ul><li>The decline brings YTD losses for the paper <a href=\"http://blogs.barrons.com/incomeinvesting/2013/10/14/puerto-rico-munis-down-6-6-in-october-sp-dji/?mod=BOL_hpp_blog_ii\" target=\"_blank\">to nearly 25%</a>, contrasting with the a broader index off just 0.4% this month and 3.9% YTD.</li><li>The news isn't helping municipal bond insurers Ambac (<a href='https://seekingalpha.com/symbol/AMBC' title='Ambac Financial'>AMBC</a> <font color='red'>-2.3%</font>) and Assured Guaranty (<a href='https://seekingalpha.com/symbol/AGO' title='Assured Guaranty Ltd.'>AGO</a> <font color='red'>-0.2%</font>), though MBIA (<a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a> <font color='green'>+0.9%</font>) is heading higher. Between them, according to BTIG's Mark Palmer, the group<a href=\"http://blogs.barrons.com/incomeinvesting/2013/10/03/should-u-s-backstop-puerto-rico-muni-debt/?mod=yahoobarrons\" target=\"_blank\"> has about $13.5B in exposure</a> to the island's debt. They've been \"trading as second derivatives\" of investor sentiment on the ability of Puerto Rico to work its way out of its fiscal issues. He suggests the U.S. government ought to ponder the systemic risk of the territory's municipal debt, and even consider a bailout.</li></ul><div class=\"tiny-share-widget\" data-id=\"1326792\" data-linked=\"Puerto Rico munis plummet 6.6% in October\" data-tweet=\"$AMBC $AMBC $AGO - Puerto Rico munis plummet 6.6% in October https://seekingalpha.com/news/1326792-puerto-rico-munis-plummet-6_6-percent-in-october?source=tweet\" data-url=\"https://seekingalpha.com/news/1326792-puerto-rico-munis-plummet-6_6-percent-in-october\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326782\" data-ts=\"1381769253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSC\" target=\"_blank\">HSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326782-harsco-corp-jumps-after-bb-and-t-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harsco Corp. jumps after BB&amp;T upgrade</a></h4><ul>\n<li>Harsco Corporation (<a href=\"https://seekingalpha.com/symbol/HSC\" title=\"Harsco Corporation\">HSC</a> <font color=\"green\">+4.2%</font>) is trading notably higher on the session.</li>\n<li>Earlier, BB&amp;T <a href=\"http://www.streetinsider.com/Upgrades/BB%26T+Capital+Upgrades+Harsco+Corporation+%28HSC%29+to+Buy/8772964.html\" target=\"_blank\">upgraded</a> the shares to Buy from Hold.</li>\n<li>Price target is $32, representing a <font color=\"green\">26%</font> upside from Friday's close.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1326782\" data-linked=\"Harsco Corp. jumps after BB&amp;T upgrade\" data-tweet=\"$HSC - Harsco Corp. jumps after BB&amp;T upgrade https://seekingalpha.com/news/1326782-harsco-corp-jumps-after-bb-and-t-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1326782-harsco-corp-jumps-after-bb-and-t-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326772\" data-ts=\"1381769151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326772-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/VISN\" title=\"VisionChina Media, Inc.\">VISN</a> <font color=\"green\">+39%</font>. <a href=\"https://seekingalpha.com/symbol/FU\" title=\"FAB Universal Corp.\">FU</a> <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/IHT\" title=\"Innsuites Hospitality Trust\">IHT</a> <font color=\"green\">+24%</font>. IDI <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/HPJ\" title=\"Highpower International, Inc.\">HPJ</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/FWM\" title=\"Fairway Group Holdings Corp.\">FWM</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/AMCN\" title=\"AirMedia Group Inc\">AMCN</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/EDN\" title=\"Empresa Distribuidora y Comercializadora Norte S.A.\">EDN</a> <font color=\"green\">+11%</font>. STSI <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/KLIC\" title=\"Kulicke and Soffa Industries, Inc.\">KLIC</a> <font color=\"green\">+10%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> CNDO <font color=\"red\">-67%</font>. <a href=\"https://seekingalpha.com/symbol/GRO\" title=\"Agria Corporation\">GRO</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/RNA\" title=\"Prosensa Holding N.V.\">RNA</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/AMCF\" title=\"Andatee China Marine Fuel Services Corporation\">OTC:AMCF</a> <font color=\"red\">-8%</font>. PSDV <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/KGJI\" title=\"KINGOLD JEWELRY\">KGJI</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/EXPE\" title=\"Expedia, Inc.\">EXPE</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/STML\" title=\"Stemline Therapeutics\">STML</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/GORO\" title=\"Gold Resource Corporation\">GORO</a> <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1326772\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$VISN $FU $IHT - Midday Gainers / Losers https://seekingalpha.com/news/1326772-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1326772-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326752\" data-ts=\"1381768852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FU\" target=\"_blank\">FU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326752-fab-universal-climbs-on-jim-rogers-bull-thesis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FAB Universal climbs on Jim Rogers&#39; bull thesis</a></h4><ul>     <li>FAB Universal (<a href=\"https://seekingalpha.com/symbol/FU\" title=\"FAB Universal Corp.\">FU</a> <font color=\"green\">+28.4%</font>) shares climb after Jim Rogers discussed his investment in the company, whose board he sits on, with <em><a href=\"http://online.barrons.com/article/SB50001424053111903320604579115481762256534.html#articleTabs_article%3D0\" target=\"_blank\">Barron's</a></em>. Rogers' bull thesis centers on the Chinese's government's intent to shore up intellectual property rights enforcement.</li>     <li>FU shares had been beaten <font color=\"red\">down 56%</font> through last week from 52-week highs notched in Sept. after a number of investors <a href=\"https://seekingalpha.com/currents/post/1301472\" target=\"_blank\">argued</a> that the company was a promoted reverse merger weighed by the underappreciated prospect of significant share dilution.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1326752\" data-linked=\"FAB Universal climbs on Jim Rogers&#39; bull thesis\" data-tweet=\"$FU - FAB Universal climbs on Jim Rogers&#39; bull thesis https://seekingalpha.com/news/1326752-fab-universal-climbs-on-jim-rogers-bull-thesis?source=tweet\" data-url=\"https://seekingalpha.com/news/1326752-fab-universal-climbs-on-jim-rogers-bull-thesis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326672\" data-ts=\"1381766386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GORO\" target=\"_blank\">GORO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326672-gold-resource-minus-7_2-percent-on-production-numbers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Resource -7.2% on production numbers</a></h4><ul>     <li>Gold Resource (<a href=\"https://seekingalpha.com/symbol/GORO\" title=\"Gold Resource Corporation\">GORO</a> <font color=\"red\">-7.2%</font>) reports preliminary Q3 production of 21.2K gold equivalent oz. and maintains its FY 2013 outlook for 80K-100K gold equivalent oz.</li>     <li>GORO says construction remains on track to deliver the complete Aguila mill  expansion of 1,500/day metric tons by year-end 2013, and development of the Arista underground mine continues.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1326672\" data-linked=\"Gold Resource -7.2% on production numbers\" data-tweet=\"$GORO - Gold Resource -7.2% on production numbers https://seekingalpha.com/news/1326672-gold-resource-minus-7_2-percent-on-production-numbers?source=tweet\" data-url=\"https://seekingalpha.com/news/1326672-gold-resource-minus-7_2-percent-on-production-numbers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326622\" data-ts=\"1381765174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NR\" target=\"_blank\">NR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326622-newpark-resources-cut-to-neutral-at-global-hunter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newpark Resources cut to Neutral at Global Hunter</a></h4><ul>     <li>Newpark Resources (<a href=\"https://seekingalpha.com/symbol/NR\" title=\"Newpark Resources Inc.\">NR</a> <font color=\"red\">-2.9%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/Global+Hunter+Securities+Downgrades+Newpark+Resources+%28NR%29+to+Neutral/8773848.html\" target=\"_blank\">downgraded</a> to Neutral from Accumulate with a $13 price target (from $14) at Global Hunter.</li>\n<li>The firm models NR posting a slight beat this quarter vs. the Street but thinks the stock is valued properly, seeking more clarity on how to replace the potential lost earnings from environmental services, a more firm outlook for fluids margins reaching and sustaining low double digits, and for the market to better understand the P&amp;L impact of the spill containment system.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1326622\" data-linked=\"Newpark Resources cut to Neutral at Global Hunter\" data-tweet=\"$NR - Newpark Resources cut to Neutral at Global Hunter https://seekingalpha.com/news/1326622-newpark-resources-cut-to-neutral-at-global-hunter?source=tweet\" data-url=\"https://seekingalpha.com/news/1326622-newpark-resources-cut-to-neutral-at-global-hunter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326562\" data-ts=\"1381763845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326562-aegis-confident-regarding-vascepa-panel-vote\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegis confident regarding Vascepa panel vote</a></h4><ul>\n<li>Aegis is out <a href=\"http://www.streetinsider.com/Analyst+Comments/Amarin+%28AMRN%29+Vascepa+Briefing+Docs+Not+Nearly+as+Bad+as+Market+Thinks+-+Analyst/8773661.html\" target=\"_blank\">defending</a> Amarin (<a href=\"https://seekingalpha.com/symbol/AMRN\" title=\"Amarin Corporation PLC\">AMRN</a> <font color=\"red\">-4.4%</font>) amid a <a href=\"https://seekingalpha.com/currents/post/1325052\" target=\"_blank\">sell-off</a> that has taken the stock down some <font color=\"red\">22%</font> from where it was trading Friday before the FDA <a href=\"https://seekingalpha.com/currents/post/1324902\" target=\"_blank\">released briefing documents</a> for an upcoming advisory committee meeting for <a href=\"https://seekingalpha.com/currents/search?query=vascepa\" target=\"_blank\">Vascepa</a>.</li>\n<li>\"In our view, the briefing documents were not anywhere near as negative as initial commentary would have investors believe,\" analyst Ram Selvaraju says, adding that Aegis remains confident \"that the panel vote is likely to ratify [the] view that Vascepa is a safe  and effective drug for the treatment of mixed dyslipidemia.\"</li>\n<li>\"A meta-analysis of 29 Western prospective studies spanning over 260K  individuals showed a correlation between triglyceride-lowering and  cardiovascular benefit,\" Selvaraju notes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1326562\" data-linked=\"Aegis confident regarding Vascepa panel vote\" data-tweet=\"$AMRN - Aegis confident regarding Vascepa panel vote https://seekingalpha.com/news/1326562-aegis-confident-regarding-vascepa-panel-vote?source=tweet\" data-url=\"https://seekingalpha.com/news/1326562-aegis-confident-regarding-vascepa-panel-vote\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326432\" data-ts=\"1381761904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPE\" target=\"_blank\">EXPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326432-deutsche-on-expedia-checks-management-changes-point-to-trouble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche on Expedia: Checks, management changes point to trouble</a></h4><ul>     <li>Deutsche's <a href=\"http://www.marketwatch.com/story/expedia-shares-off-8-as-deutsche-bank-cuts-rating-2013-10-14\" target=\"_blank\">Ross Sandler,</a> who has <a href=\"https://seekingalpha.com/currents/post/1326192\" target=\"_blank\">downgraded</a> Expedia (<a href=\"https://seekingalpha.com/symbol/EXPE\" title=\"Expedia, Inc.\">EXPE</a> <font color=\"red\">-7.8%</font>) to Hold, says checks indicate the company is \"facing much more intense competition in the U.S. market.\" He's also worried about Expedia's decision to shake up Hotels.com's management.</li>     <li>Expedia crashed in July after <a href=\"https://seekingalpha.com/currents/post/1164692\" target=\"_blank\">missing Q2 estimates</a> and more or less <a href=\"https://seekingalpha.com/currents/post/1165932\" target=\"_blank\">admitting</a> it lost share during the quarter to Priceline (PCLN <font color=\"red\">-1.1%</font>). <a href=\"https://seekingalpha.com/currents/post/1197772\" target=\"_blank\">In August</a>, Deutsche reported its checks suggested Expedia is taking back lost share.</li>     <li>Priceline and other online travel peers are off moderately. <a href=\"https://seekingalpha.com/symbol/TRIP\" title=\"TripAdvisor Inc.\">TRIP</a> <font color=\"red\">-1%</font>. <a href=\"https://seekingalpha.com/symbol/TZOO\" title=\"Travelzoo Inc\">TZOO</a> <font color=\"red\">-2.1%</font>. <a href=\"https://seekingalpha.com/symbol/OWW\" title=\"Orbitz Worldwide, Inc.\">OWW</a> <font color=\"red\">-2.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1326432\" data-linked=\"Deutsche on Expedia: Checks, management changes point to trouble\" data-tweet=\"$EXPE $EXPE $BKNG - Deutsche on Expedia: Checks, management changes point to trouble https://seekingalpha.com/news/1326432-deutsche-on-expedia-checks-management-changes-point-to-trouble?source=tweet\" data-url=\"https://seekingalpha.com/news/1326432-deutsche-on-expedia-checks-management-changes-point-to-trouble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326402\" data-ts=\"1381761258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHR\" target=\"_blank\">WHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326402-whirlpool-tumbles-on-appliance-demand-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whirlpool tumbles on appliance demand report</a></h4><ul><li>Whirlpool (<a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a> <font color='red'>-6.5%</font>) shares are down sharply on heavy volume after Cleveland Research <a href=\"http://www.streetinsider.com/Analyst+Comments/Whirlpool+%28WHR%29+Declines+on+Reports+of+Weak+Appliance+Demand/8773775.html\" target=\"_blank\">issues</a> a note that appliance demand has softened in Sept. (shipments are seen up 5%-7% YoY vs. Aug.'s 15%).</li><li>Cleveland, which has a neutral rating on WHR, thinks Whirlpool will still hit Q3 EPS numbers despite weakening trends.</li></ul><div class=\"tiny-share-widget\" data-id=\"1326402\" data-linked=\"Whirlpool tumbles on appliance demand report\" data-tweet=\"$WHR - Whirlpool tumbles on appliance demand report https://seekingalpha.com/news/1326402-whirlpool-tumbles-on-appliance-demand-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1326402-whirlpool-tumbles-on-appliance-demand-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326262\" data-ts=\"1381759216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHR\" target=\"_blank\">WHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326262-whirlpool-slumps-in-early-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whirlpool slumps in early trading</a></h4><ul> <li>Shares of Whirlpool (<a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a> <font color='red'>-7%</font>) fall hard on heavy volume.</li> <li>Investors seem unnerved by the increasing pace of <a href=\"https://seekingalpha.com/currents/post/1326072\" target=\"_blank\">reports</a> coming in indicating U.S. consumers plan to hold back on buying items for their households.</li> <li>Whirlpool has also been susceptible to bouts of momentum trading swings in the past.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1326262\" data-linked=\"Whirlpool slumps in early trading\" data-tweet=\"$WHR - Whirlpool slumps in early trading https://seekingalpha.com/news/1326262-whirlpool-slumps-in-early-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/1326262-whirlpool-slumps-in-early-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326192\" data-ts=\"1381758161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326192-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul><li>Alcatel-Lucent (ALU <font color='green'>+1.4%</font>) has been upgraded to Overweight by Barclays, and Ericsson (<a href='https://seekingalpha.com/symbol/ERIC' title='LM Ericsson Telephone Company'>ERIC</a> <font color='red'>-3.3%</font>) cut to Underweight.</li><li>AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+1.4%</font>) has been upgraded to Outperform by Wedbush.</li><li>Stratasys (<a href='https://seekingalpha.com/symbol/SSYS' title='Stratasys, Inc.'>SSYS</a> <font color='green'>+2.2%</font>) has been upgraded to Buy by Dougherty &amp; Co.</li><li>Glu Mobile (<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a> <font color='green'>+1.3%</font>) has been upgraded to Buy by B. Riley.</li><li>Mattson (<a href='https://seekingalpha.com/symbol/MTSN' title='Mattson Technology, Inc.'>MTSN</a> <font color='green'>+4.9%</font>) has been upgraded to Buy by B. Riley.</li><li>Expedia (<a href='https://seekingalpha.com/symbol/EXPE' title='Expedia, Inc.'>EXPE</a> <font color='red'>-6.9%</font>)&nbsp; has been cut to Hold by Deutsche.</li><li>Atmel (<a href='https://seekingalpha.com/symbol/ATML' title='Atmel Corporation'>ATML</a> <font color='red'>-1.9%</font>) has been cut to Sector Perform by Pac Crest.</li><li>As part of a coverage launch for chip equipment stocks, KLA-Tencor (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a> <font color='green'>+0.6%</font>) and Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='red'>-0.4%</font>) have been started at Overweight by JPMorgan, and Applied Materials (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color='red'>-1.2%</font>) has been started at Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"1326192\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$NOK $NOK $ERIC - A roundup of tech ratings changes https://seekingalpha.com/news/1326192-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1326192-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326172\" data-ts=\"1381757393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATRS\" target=\"_blank\">ATRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326172-antares-gets-fda-approval-for-otrexup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antares gets FDA approval for Otrexup</a></h4><ul>\n<li>The FDA approves Antares' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ATRS\" title=\"Antares Pharma Inc.\">ATRS</a>) <a href=\"https://seekingalpha.com/currents/search?query=otrexup\" target=\"_blank\">Otrexup</a> for adults with severe active rheumatoid arthritis \"who       have had an insufficient therapeutic response to or are intolerant of an       adequate trial of first line therapy including full dose non-steroidal       anti-inflammatory agents, or for children with active polyarticular       juvenile idiopathic arthritis [and for] adult use for symptomatic control of severe recalcitrant,       disabling psoriasis that is not adequately responsive to other forms of       therapy.\" (PR)</li>\n<li>The approval was widely expected and has been discussed by several SA contributors including <a href=\"https://seekingalpha.com/article/1722482-important-upcoming-catalyst-for-antares-fda-decision-expected-october-14\" target=\"_blank\">Stock Matusow</a>, <a href=\"https://seekingalpha.com/article/1738692-antares-otrexup-ready-for-fda-approval\" target=\"_blank\">Beacon VP Investments</a>, and <a href=\"https://seekingalpha.com/article/1741532-antares-will-change-ra-treatment-with-the-introduction-of-otrexup\" target=\"_blank\">Paul Reed</a>.</li>\n<li>ATRS <font color=\"green\">+12.8%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1326172\" data-linked=\"Antares gets FDA approval for Otrexup\" data-tweet=\"$ATRS - Antares gets FDA approval for Otrexup https://seekingalpha.com/news/1326172-antares-gets-fda-approval-for-otrexup?source=tweet\" data-url=\"https://seekingalpha.com/news/1326172-antares-gets-fda-approval-for-otrexup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326162\" data-ts=\"1381757391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEF\" target=\"_blank\">TEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326162-telefonica-reportedly-looking-to-sell-czech-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telefonica reportedly looking to sell Czech unit</a></h4><ul>     <li><a href=\"http://www.businessweek.com/news/2013-10-14/telefonica-said-to-start-sale-of-3-dot-6-billion-czech-phone-stake\" target=\"_blank\">Bloomberg reports</a> Telefonica (NYSE:<a href='https://seekingalpha.com/symbol/TEF' title='Telefonica S.A.'>TEF</a>) has hired Goldman and SocGen to find a buyer for Telefonica Czech Republic, in which it owns a 69% stake (currently valued at $3.6B). Shares of the Czech subsidiary are <font color='green'>up 4.4%</font> on European exchanges.</li>     <li>Telefonica <a href=\"https://seekingalpha.com/currents/post/1005071\" target=\"_blank\">has been rumored</a> to be weighing a sale of the business for a while, as the European/Latin American carrier pushes works to lower its net debt (still &euro;49.8B at the end of Q2). Like many other European carriers, the Telefonica Czech Republic has been seeing declining revenue (-7.8% Y/Y in Q2) thanks to nosediving voice/text-messaging activity.</li>     <li>Telefonica <a href=\"https://seekingalpha.com/currents/post/1100712\" target=\"_blank\">unloaded its Irish unit</a> for &euro;850M earlier this year, but also recently <a href=\"https://seekingalpha.com/currents/post/1297032\" target=\"_blank\">struck a deal</a> to raise its Telecom Italia stake.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1326162\" data-linked=\"Telefonica reportedly looking to sell Czech unit\" data-tweet=\"$TEF - Telefonica reportedly looking to sell Czech unit https://seekingalpha.com/news/1326162-telefonica-reportedly-looking-to-sell-czech-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/1326162-telefonica-reportedly-looking-to-sell-czech-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326092\" data-ts=\"1381756579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326092-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/ATRS\" title=\"Antares Pharma Inc.\">ATRS</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/FU\" title=\"FAB Universal Corp.\">FU</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/PLX\" title=\"Protalix BioTherapeutics, Inc\">PLX</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/KLIC\" title=\"Kulicke and Soffa Industries, Inc.\">KLIC</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/AEPI\" title=\"AEP Industries Inc.\">AEPI</a> <font color=\"green\">+6%</font>.</li>\n<li>\n<b>Losers:</b> CNDO <font color=\"red\">-68%</font>. <a href=\"https://seekingalpha.com/symbol/MY\" title=\"China Ming Yang Wind Power Group Limited\">MY</a> <font color=\"red\">-5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1326092\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$ATRS $FU $PLX - Premarket Gainers / Losers https://seekingalpha.com/news/1326092-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1326092-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326042\" data-ts=\"1381755593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATI\" target=\"_blank\">ATI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326042-allegheny-tech-sees-q3-sales-below-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegheny Tech sees Q3 sales below estimates</a></h4><ul>     <li>Allegheny Tech (NYSE:<a href=\"https://seekingalpha.com/symbol/ATI\" title=\"Allegheny Technologies Incorporated\">ATI</a>) <font color=\"red\">-2.9%</font> premarket after issuing Q3 sales guidance of ~$970M vs. $1.15B analyst consensus, citing continued lower shipments associated with many high-value and standard products, lower base-selling prices for many products, and the impact of higher raw material input costs for products with longer manufacturing cycle times.</li>     <li>ATI says it is restructuring its engineered products segment due to the pending sale of its tungsten materials business; it is closing its fabricated components business and intends to divest its iron casting business.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1326042\" data-linked=\"Allegheny Tech sees Q3 sales below estimates\" data-tweet=\"$ATI - Allegheny Tech sees Q3 sales below estimates https://seekingalpha.com/news/1326042-allegheny-tech-sees-q3-sales-below-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/1326042-allegheny-tech-sees-q3-sales-below-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1326002\" data-ts=\"1381754868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUVA\" target=\"_blank\">NUVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1326002-goldman-cuts-nuvasive-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman cuts NuVasive to sell</a></h4><ul>\n<li>Goldman <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+NuVasive+%28NUVA%29+to+Sell/8773093.html\" target=\"_blank\">downgrades</a> NuVasive (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NUVA\" title=\"NuVasive, Inc.\">NUVA</a>) to Sell.</li>\n<li>Analyst David Roman says \"conversations with industry participants\" suggest cervical spinal implants (which represent 10-12% of NUVA's sales) could be pressured going forward even as \"lumbar fusion insurer pushback seems to have eased.\"</li>\n<li>Furthermore, Roman notes that \"the <a href=\"https://seekingalpha.com/currents/post/1180682\" target=\"_blank\">ongoing OIG investigation</a> into NUVA's CMS reimbursement filings is ... a risk that is hard to quantify.\"</li>\n<li>Price target cut to $22 (from $25) representing a <font color=\"red\">16%</font> discount to Friday's close.</li>\n<li>NUVA<font color=\"red\"> -2.7%</font> premarket (light volume).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1326002\" data-linked=\"Goldman cuts NuVasive to sell\" data-tweet=\"$NUVA - Goldman cuts NuVasive to sell https://seekingalpha.com/news/1326002-goldman-cuts-nuvasive-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/1326002-goldman-cuts-nuvasive-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1325982\" data-ts=\"1381754384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMED\" target=\"_blank\">GMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1325982-globus-medical-falls-on-goldman-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globus Medical falls on Goldman downgrade</a></h4><ul>\n<li>\"We see the recent Aetna policy change to deny coverage for cervical interbody devices as shaving approximately  0.8%-0.9% off of our prior 2014 revenue estimates alone,\" Goldman's David Roman says, adding that the figure \"could become more meaningful if additional commercial payers follow suit.\"</li>\n<li>Globus Medical (NYSE:<a href=\"https://seekingalpha.com/symbol/GMED\" title=\"Globus Medical\">GMED</a>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+Globus+Medical+%28GMED%29+to+Neutral/8773096.html\" target=\"_blank\">downgraded</a> to Neutral from Buy and Goldman's FY14, FY15, and FY16 revenue projections are cut by 0.9%, 1%, and 1.4% respectively.</li>\n<li>Price target cut to $18 from $19.</li>\n<li>GMED <font color=\"red\">-3.6%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1325982\" data-linked=\"Globus Medical falls on Goldman downgrade\" data-tweet=\"$GMED - Globus Medical falls on Goldman downgrade https://seekingalpha.com/news/1325982-globus-medical-falls-on-goldman-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1325982-globus-medical-falls-on-goldman-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1325962\" data-ts=\"1381754181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPR\" target=\"_blank\">TPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1325962-coach-lower-after-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coach lower after downgrade</a></h4><ul>     <li>Shares of Coach (COH) slip in premarket trading after some retail <a href=\"https://seekingalpha.com/currents/post/1325782\" target=\"_blank\">channel checks</a> indicate the company has lost some market share to Michael Kors.</li>     <li>The trend was strong enough to prompt Canaccord to take its rating <a href=\"https://twitter.com/Benzinga/status/389698235259826176\" target=\"_blank\">down</a> to Hold from Buy.</li> <li>COH <font color=\"red\">-1.6%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1325962\" data-linked=\"Coach lower after downgrade\" data-tweet=\"$TPR - Coach lower after downgrade https://seekingalpha.com/news/1325962-coach-lower-after-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1325962-coach-lower-after-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1325872\" data-ts=\"1381752610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDE\" target=\"_blank\">CDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1325872-coeur-mining-enjoying-barrons-bounce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coeur Mining enjoying Barron&#39;s bounce</a></h4><ul>     <li>Coeur Mining (NYSE:<a href=\"https://seekingalpha.com/symbol/CDE\" title=\"Coeur Mining, Inc.\">CDE</a>) <font color=\"green\">+2.8%</font> premarket after a weekend <em>Barron's</em> article speculates <a href=\"http://online.barrons.com/article/SB50001424053111903891504579123471341975930.html\" target=\"_blank\">shares could jump 50%</a> after falling ~60% over the past year, as the silver miner restructures its operations and  sentiment improves on the sector.</li>     <li>CDE is posting losses but is profitable on an  operating cash flow basis, it has a solid balance sheet with  little net debt, and the stock is cheap at around half of book value.</li>\n<li>Efforts to improve efficiencies at its mines appear to be working; in the June quarter,  production at the Palmarejo mine, the biggest contributor to CDE's cash flow, rebounded Q/Q with silver  production up 24% and gold up 23%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1325872\" data-linked=\"Coeur Mining enjoying Barron&#39;s bounce\" data-tweet=\"$CDE - Coeur Mining enjoying Barron&#39;s bounce https://seekingalpha.com/news/1325872-coeur-mining-enjoying-barrons-bounce?source=tweet\" data-url=\"https://seekingalpha.com/news/1325872-coeur-mining-enjoying-barrons-bounce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1325852\" data-ts=\"1381752335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLX\" target=\"_blank\">PLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1325852-protalix-reports-phase-1-results-for-prxminus-112-in-gaucher-disease\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Protalix reports Phase 1 results for PRX-112 in Gaucher disease</a></h4><ul>\n<li>Protalix BioTherapeutics (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/PLX\" title=\"Protalix BioTherapeutics, Inc\">PLX</a>) says  oral glucocerebrosidase (PRX-112) was well-tolerated in a Phase 1 clinical trial in patients with Gaucher disease.</li>\n<li>PLX also says the enzyme was present in patients' blood circulation and demonstrated biological activity, suggesting the oral delivery of enzymes using plant cells as a delivery platform may have potential. (PR)</li>\n<li>PLX <font color=\"green\">+5%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1325852\" data-linked=\"Protalix reports Phase 1 results for PRX-112 in Gaucher disease\" data-tweet=\"$PLX - Protalix reports Phase 1 results for PRX-112 in Gaucher disease https://seekingalpha.com/news/1325852-protalix-reports-phase-1-results-for-prxminus-112-in-gaucher-disease?source=tweet\" data-url=\"https://seekingalpha.com/news/1325852-protalix-reports-phase-1-results-for-prxminus-112-in-gaucher-disease\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1325822\" data-ts=\"1381751856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STP\" target=\"_blank\">STP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1325822-more-italian-headaches-for-suntech\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More Italian headaches for Suntech</a></h4><ul>     <li>Suntech Power (NYSE:<a href=\"https://seekingalpha.com/symbol/STP\" title=\"Suntech Power Holdings Co., Ltd.\">STP</a>) <font color=\"red\">-4%</font> premarket following news the seizure of more solar fields developed with the backing of 88%-owned Global Solar Fund, bringing to 47 confiscated solar parks adding up to 37.8 MW, or 26.9% of GSF-backed generating capacity.</li>     <li>The Court of Brindisi appoints judicial administrators for 27 sites seized Sept. 19, and authorizes the fields to continue operations and receive feed-in tariffs according to court guidelines.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1325822\" data-linked=\"More Italian headaches for Suntech\" data-tweet=\"$STP - More Italian headaches for Suntech https://seekingalpha.com/news/1325822-more-italian-headaches-for-suntech?source=tweet\" data-url=\"https://seekingalpha.com/news/1325822-more-italian-headaches-for-suntech\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1325642\" data-ts=\"1381742485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/E\" target=\"_blank\">E</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1325642-global-stocks-mixed-as-u-s-debt-deadline-draws-ever-nearer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global stocks mixed as U.S. debt deadline draws ever nearer</a></h4><ul>   <li>Asian and European shares are <a href=\"http://www.reuters.com/article/2013/10/14/markets-global-idUSL6N0I40PK20131014\" target=\"_blank\">mixed</a>, and U.S. stocks lower as the deadlock in Washington continued over the weekend. It appears that markets are caught between hope that the debt ceiling will be lifted time and fear that it won't.</li>    <li>An unexpected fall in Chinese exports has also added some negative sentiment.</li>    <li>However, Chinese shares <font color=\"green\">rose 0.4%</font>, with <a href=\"http://www.bloomberg.com/news/2013-10-14/china-s-stock-futures-rise-after-biggest-weekly-gain-in-month.html\" target=\"_blank\">train companies soaring</a> on  speculation they could participate in the construction of Thailand's high-speed train system.</li>    <li>Japan, Hong Kong closed;  India <font color=\"green\">+0.25%</font>.</li>    <li>EU Stoxx 50 <font color=\"red\">-0.1%</font>, London <font color=\"green\">+0.1%</font>, Paris <font color=\"red\">-0.3%</font>, Frankfurt <font color=\"red\">-0.3%</font>, Milan flat, Madrid <font color=\"green\">+0.2%</font>.</li>    <li>U.S. Stock futures: Dow <font color=\"red\">-0.65%</font>. S&amp;P <font color=\"red\">-0.7%</font>. Nasdaq <font color=\"red\">-0.5%</font>.</li>    <li>ETFs - <a href=\"https://seekingalpha.com/symbol/EZU\" title=\"iShares MSCI Eurozone ETF\">EZU</a>, <a href=\"https://seekingalpha.com/symbol/VGK\" title=\"Vanguard FTSE Europe ETF\">VGK</a>, <a href=\"https://seekingalpha.com/symbol/FEZ\" title=\"SPDR EURO STOXX 50 ETF\">FEZ</a>, <a href=\"https://seekingalpha.com/symbol/EPV\" title=\"ProShares UltraShort FTSE Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/IEV\" title=\"iShares Europe ETF\">IEV</a>,  <a href=\"https://seekingalpha.com/symbol/ADRU\" title=\"Invesco BLDRS Europe 100 ADR Index ETF\">ADRU</a>, <a href=\"https://seekingalpha.com/symbol/FEP\" title=\"First Trust Europe AlphaDEX ETF\">FEP</a>, <a href=\"https://seekingalpha.com/symbol/FDD\" title=\"First Trust Dow Jones STOXX European Select Dividend 30 Index ETF\">FDD</a>, <a href=\"https://seekingalpha.com/symbol/UPV\" title=\"ProShares Ultra FTSE Europe ETF\">UPV</a>, <a href=\"https://seekingalpha.com/symbol/EPV\" title=\"ProShares UltraShort FTSE Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/DFE\" title=\"WisdomTree Europe SmallCap Dividend ETF\">DFE</a>, <a href=\"https://seekingalpha.com/symbol/FEU\" title=\"SPDR STOXX Europe 50 ETF\">FEU</a>, <a href=\"https://seekingalpha.com/symbol/FEEU\" title=\"Barclays ETN+ FI Enhanced Europe 50 ETN\">FEEU</a>, <a href=\"https://seekingalpha.com/symbol/ADRA\" title=\"Invesco BLDRS Asia 50 ADR Index ETF\">ADRA</a>, <a href=\"https://seekingalpha.com/symbol/AIA\" title=\"iShares Asia 50 ETF\">AIA</a>, <a href=\"https://seekingalpha.com/symbol/VPL\" title=\"Vanguard FTSE Pacific ETF\">VPL</a>, <a href=\"https://seekingalpha.com/symbol/ASDR\" title=\"VelocityShares Emerging Asia Depositary Receipt ETF\">ASDR</a>, <a href=\"https://seekingalpha.com/symbol/AAXJ\" title=\"iShares MSCI All Country Asia ex-Japan Index ETF\">AAXJ</a>, <a href=\"https://seekingalpha.com/symbol/AXJS\" title=\"iShares MSCI All Country Asia ex-Japan Small Cap Index ETF\">AXJS</a>, <a href=\"https://seekingalpha.com/symbol/EPP\" title=\"iShares MSCI Pacific ex Japan ETF\">EPP</a>, <a href=\"https://seekingalpha.com/symbol/GMF\" title=\"SPDR S&amp;P Emerging Asia Pacific ETF\">GMF</a>, <a href=\"https://seekingalpha.com/symbol/GMFS\" title=\"SPDR S&amp;P Small Cap Emerging Asia Pacific ETF\">GMFS</a>, <a href=\"https://seekingalpha.com/symbol/AXJL\" title=\"WisdomTree Asia-Pacific ex-Japan ETF\">AXJL</a>, <a href=\"https://seekingalpha.com/symbol/UXJ\" title=\"ProShares Ultra MSCI Pacific Ex-Japan ETF\">UXJ</a>, <a href=\"https://seekingalpha.com/symbol/JPX\" title=\"ProShares UltraShort MSCI Pacific ex-Japan ETF\">JPX</a>, <a href=\"https://seekingalpha.com/symbol/PAF\" title=\"Invesco FTSE RAFI Asia Pacific ex-Japan Portfolio ETF\">PAF</a>, <a href=\"https://seekingalpha.com/symbol/ASEA\" title=\"Global X Southeast Asia ETF\">ASEA</a>, <a href=\"https://seekingalpha.com/symbol/EEMA\" title=\"iShares MSCI Emerging Markets Asia Index ETF\">EEMA</a>, <a href=\"https://seekingalpha.com/symbol/DVYA\" title=\"iShares Asia/Pacific Dividend ETF\">DVYA</a>, <a href=\"https://seekingalpha.com/symbol/FXI\" title=\"iShares China Large-Cap ETF\">FXI</a>, <a href=\"https://seekingalpha.com/symbol/GXC\" title=\"SPDR S&amp;P China ETF\">GXC</a>, <a href=\"https://seekingalpha.com/symbol/PGJ\" title=\"Invesco Golden Dragon China Portfolio ETF\">PGJ</a>, <a href=\"https://seekingalpha.com/symbol/YAO\" title=\"Invesco China All-Cap ETF\">YAO</a>, <a href=\"https://seekingalpha.com/symbol/FCHI\" title=\"iShares FTSE China (HK-Listed) Index ETF\">FCHI</a>, <a href=\"https://seekingalpha.com/symbol/PEK\" title=\"VanEck Vectors ChinaAMC CSI 300 ETF\">PEK</a>, <a href=\"https://seekingalpha.com/symbol/CAF\" title=\"Morgan Stanley China A Share Fund\">CAF</a>, <a href=\"https://seekingalpha.com/symbol/YXI\" title=\"ProShares Short FTSE China 50 ETF\">YXI</a>, <a href=\"https://seekingalpha.com/symbol/XPP\" title=\"ProShares Ultra FTSE China 25 ETF\">XPP</a>, <a href=\"https://seekingalpha.com/symbol/FXP\" title=\"ProShares UltraShort FTSE China 25 ETF\">FXP</a>, <a href=\"https://seekingalpha.com/symbol/MCHI\" title=\"iShares MSCI China ETF\">MCHI</a>, <a href=\"https://seekingalpha.com/symbol/YINN\" title=\"Direxion Daily FTSE China Bull 3x Shares ETF\">YINN</a>, <a href=\"https://seekingalpha.com/symbol/YANG\" title=\"Direxion Daily FTSE China Bear 3x Shares ETF\">YANG</a>, <a href=\"https://seekingalpha.com/symbol/TCHI\" title=\"RBS China Trendpilot ETN\">TCHI</a>, CHXF, <a href=\"https://seekingalpha.com/symbol/KFYP\" title=\"KraneShares Zacks New China ETF\">KFYP</a>, <a href=\"https://seekingalpha.com/symbol/HAO\" title=\"Invesco China Small Cap ETF\">HAO</a>, <a href=\"https://seekingalpha.com/symbol/ECNS\" title=\"iShares MSCI China Small-Cap ETF\">ECNS</a>, <a href=\"https://seekingalpha.com/symbol/EFA\" title=\"iShares MSCI EAFE ETF\">EFA</a>, <a href=\"https://seekingalpha.com/symbol/IEFA\" title=\"iShares Core MSCI EAFE ETF\">IEFA</a>, <a href=\"https://seekingalpha.com/symbol/VEA\" title=\"Vanguard FTSE Developed Markets ETF\">VEA</a>, <a href=\"https://seekingalpha.com/symbol/ADRD\" title=\"Invesco BLDRS Developed Markets 100 ADR Index ETF\">ADRD</a>, <a href=\"https://seekingalpha.com/symbol/MFLA\" title=\"iPath Long Enhanced 2x MSCI EAFE Index ETN\">MFLA</a>, <a href=\"https://seekingalpha.com/symbol/EFO\" title=\"ProShares Ultra MSCI EAFE ETF\">EFO</a>, <a href=\"https://seekingalpha.com/symbol/EFU\" title=\"ProShares UltraShort MSCI EAFE ETF\">EFU</a>, <a href=\"https://seekingalpha.com/symbol/PDN\" title=\"Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid Portfolio ETF\">PDN</a>, <a href=\"https://seekingalpha.com/symbol/PIZ\" title=\"Invesco DWA Developed Markets Momentum Portfolio ETF\">PIZ</a>, <a href=\"https://seekingalpha.com/symbol/EFZ\" title=\"ProShares Short MSCI EAFE ETF\">EFZ</a>, <a href=\"https://seekingalpha.com/symbol/PXF\" title=\"Invesco FTSE RAFI Developed Markets ex-U.S. Portfolio ETF\">PXF</a>, <a href=\"https://seekingalpha.com/symbol/EFG\" title=\"iShares MSCI EAFE Growth ETF\">EFG</a>, <a href=\"https://seekingalpha.com/symbol/EFV\" title=\"iShares MSCI EAFE Value ETF\">EFV</a>, <a href=\"https://seekingalpha.com/symbol/DZK\" title=\"Direxion Daily Developed Markets Bull 3x Shares ETF\">DZK</a>, <a href=\"https://seekingalpha.com/symbol/DPK\" title=\"Direxion Daily Developed Markets Bear 3x Shares ETF\">DPK</a>, <a href=\"https://seekingalpha.com/symbol/IDLV\" title=\"Invesco S&amp;P International Developed Low Volatility ETF\">IDLV</a>, <a href=\"https://seekingalpha.com/symbol/DTH\" title=\"WisdomTree DEFA  Equity Income ETF\">DTH</a>, <a href=\"https://seekingalpha.com/symbol/DWM\" title=\"WisdomTree International Equity ETF\">DWM</a>, <a href=\"https://seekingalpha.com/symbol/URTH\" title=\"iShares MSCI World ETF\">URTH</a>, <a href=\"https://seekingalpha.com/symbol/FDTS\" title=\"First Trust Developed Markets ex-US Small Cap AlphaDEX ETF\">FDTS</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1325642\" data-linked=\"Global stocks mixed as U.S. debt deadline draws ever nearer\" data-tweet=\"$E $EZU $VGK - Global stocks mixed as U.S. debt deadline draws ever nearer https://seekingalpha.com/news/1325642-global-stocks-mixed-as-u-s-debt-deadline-draws-ever-nearer?source=tweet\" data-url=\"https://seekingalpha.com/news/1325642-global-stocks-mixed-as-u-s-debt-deadline-draws-ever-nearer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:21 AM </div></div></li>","count":36,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}